(Q51587807)

English

Lipoprotein(a) distribution in a French Canadian population and its relation to intermittent claudication (the Québec Cardiovascular Study)

scientific article published in June 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

Lipoprotein(a) distribution in a French Canadian population and its relation to intermittent claudication (the Québec Cardiovascular Study) (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

intermittent claudication

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Paul-J.‏ ‎Lupien

4

object named as

Lupien PJ

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

author name string

Cantin B

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

Moorjani S

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

Dagenais GR

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

language of work or name

0 references

publication date

1 June 1995

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

75

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

17

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

1224-1228

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

A prospective study of lipoprotein(a) and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

A dominant role of lipoprotein(a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Lp(a) levels in different types of dyslipidemia in the French population

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Intermittent claudication: prevalence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Prevalence of intermittent claudication and its effect on mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Serum lipids and high density lipoprotein cholesterol in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Turnover of lipoprotein (a) in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein(a), fibrin binding, and plasminogen activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980767-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9149(99)80767-X

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7778544

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51587807&oldid=2086718872"